Related Experiment Videos
Survival kinases in ischemic preconditioning and postconditioning.
Derek J Hausenloy1, Derek M Yellon
1The Hatter Institute and Centre for Cardiology, University College London Hospital, Chenies Mews, London, WC1E 6DB, United Kingdom.
Cardiovascular Research
|March 21, 2006
Summary
Ischemic preconditioning and postconditioning activate survival protein kinases for cardioprotection. Ischemic postconditioning, applied during reperfusion, offers a more clinically viable approach to myocardial protection.
Area of Science:
- Cardiovascular Research
- Molecular Cardiology
- Cellular Signaling
Background:
- Ischemic preconditioning mechanisms remain unclear despite extensive research.
- Cardioprotection involves complex intracellular signal transduction pathways and protein kinase cascades.
- Clinical application of ischemic preconditioning is limited due to its timing requirement before ischemia.
Purpose of the Study:
- To review the roles of protein kinases in mediating cardioprotective effects of ischemic preconditioning and postconditioning.
- To explore shared signaling pathways between preconditioning and postconditioning.
- To highlight ischemic postconditioning as a more clinically applicable cardioprotective strategy.
Main Methods:
- Review of scientific literature on ischemic preconditioning and postconditioning.
- Analysis of signal transduction pathways and protein kinase activation.
- Comparison of mechanisms between preconditioning and postconditioning.
Main Results:
- Both preconditioning and postconditioning activate survival protein kinase cascades.
- Key pathways include protein kinases C, G, A, MAPK family, PI3K-Akt, and JAK-STAT.
- Ischemic postconditioning, applied during reperfusion, is a more practical clinical approach.
Conclusions:
- Shared protein kinase pathways represent potential common targets for cardioprotection.
- Ischemic postconditioning offers a promising therapeutic strategy for myocardial protection in clinical settings.
- Further research into these kinase pathways could lead to novel treatments for acute myocardial infarction.